Here are relevant reports on : e-discovery-market
-
Glycomics Market / Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027
The global glycomics market in terms of revenue was estimated to be worth $1.8 Billion in 2022 and is poised to reach $3.7 billion by 2027, growing at a CAGR of 15.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Microscopy Market by Product [Optical Microscope: Stereo, Digital; Electron microscope: SEM, TEM, AFM, STM], Application (Pharma Mfg, Pathology, Drug Discovery, Toxicology), End User (Pharma-biopharma, Academia, Semiconductor) — Forecast to 2031
The Asia-Pacific microscopy market is projected to reach USD 2.56 billion by 2031, growing at a CAGR of 6.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Generative AI Market by Software (Foundation Models, Model Enablement & Orchestration Tools, Gen AI SaaS), Modality (Text, Code, Video, Image, Multimodal), Application (Content Management, BI & Visualization, Search & Discovery) - Global Forecast to 2032
The generative AI market is experiencing a seismic growth trajectory, projected to surge from USD 71.36 billion in 2025 to USD 890.59 billion by 2032, at a CAGR of 43.4% during the forecast period. The major players in the generative AI market include IBM (US), NVIDIA (US), OpenAI (US), Anthropic (US), Meta (US), HPE (US), AMD (US), Oracle (US), Innodata (US), iMerit (US), Salesforce (US), Telus Digital (US), Microsoft (US), Google (US), AWS (US), Adobe (US), Accenture (Ireland), Capgemini (France), Centific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), Databricks (US), Dialpad (US), Appen (Australia), Insilico Medicine (Hong Kong), Simplified (US), AI21 Labs (Israel), Hugging Face (US), Persado (US), Copy.ai (US), Synthesis AI (US), Hypotenuse AI (US), Together AI (US), Mistral AI (France), Adept (US), Stability AI (UK), Lightricks (Israel), Cohere (Canada), Writesonic (US), Inflection AI (US), Colossyan (UK), Jasper (US), Runway (US), Inworld AI (US), Typeface (US), Upstage (South Korea), H2O.ai (US), Speechify (US), Midjourney (US), Fireflies (US), Synthesia (UK), Mostly AI (Austria), Forethought (US), Character.ai (US), Cursor (US), DeepSeek (China), XAI (US), Abridge (US), Perplexity AI (US), SambaNova (US), Scale AI (US), Labelbox (US), and HQE Systems (US).
- Published: May 2025
- Price: $ 7150
- TOC Available:
-
Federated Learning Market by Application (Drug Discovery, Industrial IoT, Risk Management), Vertical (Healthcare and Life Sciences, BFSI, Manufacturing, Automotive and Transportation, Energy and Utilities) and Region - Global Forecast to 2028
As per AS-IS scenario, the global federated learning market size is projected to reach worth $210 million by 2028, at a Compound Annual Growth Rate (CAGR) of 10.6% during the forecast period. The federated learning solutions vendors have implemented various types of organic as well as inorganic growth strategies, such as new product launches, product upgradations, partnerships and agreements, business expansions, and mergers and acquisitions to strengthen their offerings in the market. The major vendors in the global federated learning solutions market include NVIDIA (US), Cloudera (US), IBM (US), Microsoft (US), Google (US), Intel(US), Owkin(US), Intellegens(UK), Edge Delta(US), Enveil(US), Lifebit(UK), DataFleets(US), Secure AI Labs(US), and Sherpa.AI(Spain).
- Published: April 2022
- Price: $ 4950
- TOC Available:
-
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
Data Resiliency Market by Component (Solutions (Data Backup & Recovery, Data Archiving & E-Discovery, Disaster Recovery), Services (Professional Services & Managed Services)), Deployment, Organization Size, Vertical, and Region - Global Forecast to 2023
The data resiliency market is projected to grow from USD 11.69 Billion in 2018 to USD 27.63 Billion by 2023, at a CAGR of 18.8% from 2018 to 2023. Increasing data generation from various sources, and growing data privacy concerns and the need to ensure data security are the factors driving the growth of the data resiliency market across the globe. Some of the major vendors of data resiliency solutions are Acronis (Switzerland), Asigra Inc. (Canada), CA Technologies (US), Carbonite, Inc. (US), CenturyLink (US), Commvault Systems, Inc. (US), IBM (US), Micro Focus (UK), Microsoft (US), NetApp (US), Quest Software, Inc. (US), Unitrends (US), Veeam Software (Switzerland), Veritas Technologies LLC (US), and VMware (US).
- Published: April 2018
- Price: $ 4950
- TOC Available:
-
Chemoinformatics Market by Application (Chemical Analysis (Chemical Databases, Chemo Metrics, Molecular Modelling), Drug Discovery (High Throughput Screening, Lead Identification and Optimization, QSAR/QSPR), Drug Validation) - Global Forecast to 2023
Growth of the chemoinformatics market is primarily driven by innovations and advancements in the drug development process, advances in the computer technology, increased demand of personalized medicine. On the other hand, cost associated with the chemoinformatics software is one of the major factors restraining the growth of this market. Whereas emerging markets are expected to provide significant growth opportunities in this market.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
In Situ Hybridization Market by Offering (Consumables, Instruments, Software), Technology (FISH (DNA FISH, RNA, PNA), CISH), Application (Cancer Diagnostics, Research, Discovery), End User (Hospitals, Pharma & Biotech, Academia) - Global Forecast to 2030
The global in situ hybridization market, valued at US$1.55 billion in 2024, stood at US$1.64 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.35 billion by the end of the period. The growth in the field of in situ hybridization (ISH) is significantly driven by ongoing advancements in technology, including high-sensitivity probes, automated systems, and multiplexing solutions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
